Phentolamine- and clonidine-induced changes in plasma neuropeptide Y-like immunoreactivity during sympathetic activation in man.
暂无分享,去创建一个
[1] P. Hjemdahl,et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. , 2008, Clinical physiology.
[2] J. Lundberg,et al. Alpha 2-adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig. , 1986, European journal of pharmacology.
[3] J. Lundberg,et al. Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. , 1985, Scandinavian journal of clinical and laboratory investigation.
[4] J. Pernow,et al. Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation , 1984, Neuroscience Letters.
[5] J. Atterhög,et al. Effects of Prazosin on Hemodynamics and Sympatho‐Adrenal Activity in Hypertensive Patients , 1983, Journal of cardiovascular pharmacology.
[6] T. Hökfelt,et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. , 1982, Acta physiologica Scandinavica.
[7] J. Lundberg,et al. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. , 1982, Acta physiologica Scandinavica.
[8] S. Z. Langer,et al. Recent Developments In Noradrenergic Neurotransmission and its Relevance to the Mechanism of Action of Certain Antihypertensive Agents , 1980, Hypertension.